DDX5 and hepatocellular carcinoma: Together, while we may beg the question of why DDX5 can delay or inhibit HCC development and malignancy, the role of DDX5 in HCC with, versus without, virus infection may involve overlapped but distinct intracellular events, extracellular events, and innate immunity events in the tumor microenvironment (TME).